Singapore Medical Devices 2020 Market is Expected Grow Rapidly

The research is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the Singapore's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

Singapore's population grew from 4.8 million in 2008 to 5.4 million in 2013, mainly due to the increase in the life expectancy (DoS, 2014). The value of the pharmaceuticals market increased from $489m in 2008 to $761m in 2013 at a CAGR of 9.3%, and this value is expected to increase further from $776m in 2014 to $873m in 2020 at a CAGR of 2.0% (Tarn et al., 2008; DoS, 2014; EDB, 2014c). In 2011, the output of the medical technology sector was SGD4.3 billion ($3.4 billion), which is expected to increase to SGD5 billion ($4 billion) in 2015 (EDB, 2014a).

Inquire before buying this research at: .

These positive growth trends can primarily be attributed to -

·         Government initiatives

·         Universal healthcare coverage

Scope for this research:

The report provides information on the healthcare, regulatory, and reimbursement landscape in Singapore, and includes -

·         Overview of the pharmaceutical market including size, segmentation, and key drivers and barriers

·         Profiles and SWOT analyses of the major players in the pharmaceutical market: Haw Par Corporation, SciGen, Pfizer, Novartis and GlaxoSmithKline

·         Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

·         Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

·         An overview of the opportunities for and challenges to growth in the Singaporean healthcare market

Reasons to buy this research:

·         This report will enhance your decision-making capability by allowing you to -

·         Develop business strategies by understanding the trends shaping and driving Singapore's healthcare market

·         Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Singapore's healthcare market in the future

·         Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

·         Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership

·         Identify, understand, and capitalize on the opportunities and challenges in Singapore's healthcare market

Complete market outlook on ‘Singapore's - Healthcare’ spread across 172 pages at .

Table of contents:

·         Overview of Pharmaceutical and Medical Device Markets

·         Market Access

·         Country Analysis of the Current Political Environment

·         Economic Indicators Country Analysis

·         Healthcare Infrastructure Country Analysis

·         Trade Associations Country Analysis

·         Opportunities and Challenges

·         List of Tables

·         List of Figures